MatthewLelegrenMD

PubMed

• 2 citations
  Management of complicated acute sinusitis in the setting of concurrent COVID-19.
  Kevin Guy, Matthew Lelegren, Kyrie Shomaker, Joseph Han, Kent Lam> ;American Journal of Otolaryngology. 2022 Aug 13
• 3 citations
  A review of phase III clinical trials of US FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposis.
  Matthew J Lelegren, Sam Y Son, Joseph K Han, Kent K Lam> ;Immunotherapy. 2022 Jun 1
• 2 citations
  Nasal Nitric Oxide as a Biomarker in the Diagnosis and Treatment of Sinonasal Inflammatory Diseases: A Review of the Literature.
  Jacob J Benedict, Matthew Lelegren, Joseph K Han, Kent Lam> ;The Annals of Otology, Rhinology, and Laryngology. 2023 Apr 1
• 6 citations
  Intraoperative Applications of Topical Corticosteroid Therapy for Chronic Rhinosinusitis.
  Matthew J. Lelegren, Randall A Bloch, Kent Lam> ;Ear, Nose, & Throat Journal. 2021 Jun 1
• 5 citations
  Variations in utilization and clinical outcomes for endoscopic sphenopalatine artery ligation and endovascular arterial embolization in a single multi-hospital network.
  Matthew J. Lelegren, Karthik Bhat, Brynn E. Sheehan, Rajan Lamichhane, Joseph K. Han, Kent Lam> ;American Journal of Otolaryngology. 2021 Apr 16
• 2 citations
  Primary cervical ganglioneuroblastoma, nodular subtype.
  Ethan K. McGann, Allison M. Goldberg, Matthew J. Lelegren, Jerrah C. Pickle, Matthew J. Bak, Jonathan Mark> ;Auris, Nasus, Larynx. 2021 Apr 15
• 22 citations
  Pharmaceutical inhibition of mTOR in the common marmoset: effect of rapamycin on regulators of proteostasis in a non-human primate
  Matthew Lelegren, Yuhong Liu, Corinna N. Ross, Suzette D. Tardif, Adam B. Salmon> ;Pathobiology of Aging & Age Related Diseases. 2016 Jun 23
• Join now to see all